Versiti Clinical Trials, Cenetron and Salus IRB are all fully accredited institutions built on AAHRPP, CAP and CLIA requirements.
Versiti Clinical Trials holds a number of accreditations across its service lines.
Versiti holds a number of accreditations and licenses nationally and across Illinois, Indiana, Michigan, Ohio and Wisconsin. View the full list.
Cenetron Central Laboratories
Cenetron maintains extensive quality systems. Our standard operating procedures are built on CAP and CLIA requirements for sample accessioning, analysis, storage, transportation and chain‑of‑custody, as well as requirements for quality management, equipment maintenance and calibration, and facility management.
Salus IRB is appropriately constituted, organized, and conducts ethical review in accordance with the U.S. Food and Drug Administration 21 CFR Parts 50 and 56, the Department of Health and Human Services 45 CFR Part 46, and the International Conference on Harmonization (ICH) Guideline for Good Clinical Practice E6(R2).
Salus IRB is registered with the United States Department of Health and Human Services (DHHS) IRB Registration System for OHRP and FDA under parent organization number IORG0005674 and registration numbers IRB00006833 (Board 1), IRB00006834 (Board 2), IRB00009473 (Board 3), IRB00013027 (Board 4), and IRB00013544 (Board 5).
Salus IRB has been fully accredited since 2009 by the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP).